×
About 82,998 results

ALLMedicine™ Anemia Center

Research & Reviews  22,970 results

Association between iron deficiency anemia and chronic daily headache: A case-control s...
https://doi.org/10.1177/03331024221143540
Cephalalgia : an International Journal of Headache; Singh RK, Kaushik RM et. al.

Feb 6th, 2023 - We aimed to determine the association between iron deficiency anemia and chronic daily headache. This case-control study was conducted in a tertiary care center in Dehradun, India. One hundred patients with chronic daily headache were randomly sel...

A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients wit...
https://doi.org/10.1007/s00280-023-04507-w
Cancer Chemotherapy and Pharmacology; Kim R, Leal AD et. al.

Feb 5th, 2023 - Guanylyl cyclase C (GCC) is highly expressed in several gastrointestinal malignancies and preclinical studies suggest that it is a promising target for antibody-based therapeutics. This phase I trial assessed the safety and tolerability of TAK-164...

Performance and safety of motorized spiral enteroscopy: a systematic review and meta-an...
https://doi.org/10.1016/j.gie.2023.01.048
Gastrointestinal Endoscopy; Papaefthymiou A, Ramai D et. al.

Feb 5th, 2023 - The introduction of motorized spiral enteroscopy (mSe) into clinical practice holds diagnostic and therapeutic potential for small bowel investigation. This systematic review with meta-analysis aims to evaluate the performance of this modality in ...

Efficacy, Safety, and Health-Related Quality of Life with Camrelizumab Plus Pemetrexed ...
https://doi.org/10.1016/j.jtho.2023.01.083
Journal of Thoracic Oncology : Official Publication of Th... Hou X, Zhou C et. al.

Feb 5th, 2023 - Systemic treatment options for non-small-cell lung cancer (NSCLC) with brain metastases (BMs) are scarce. We evaluated the activity and safety of camrelizumab plus chemotherapy as first-line therapy in advanced non-squamous NSCLC patients with BMs...

Zinc for infection prevention in children with sickle cell anemia: a randomized double-...
https://doi.org/10.1182/bloodadvances.2022008539
Blood Advances; Namazzi R, Opoka RO et. al.

Feb 4th, 2023 - Data from small clinical trials in the USA and India suggest zinc supplementation reduces infection in adolescents and adults with sickle cell anemia (SCA), but no studies of zinc supplementation for infection prevention have been conducted in you...

see more →

Guidelines  27 results

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740554
Gastroenterology Shah SC, Piazuelo MB et. al.

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 12th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 31st, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 31st, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 19th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

see more →

Drugs  1,252 results see all →

Clinicaltrials.gov  2,867 results

REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
https://clinicaltrials.gov/ct2/show/NCT04409080

Feb 3rd, 2023 - The primary objective of this study is to assess the safety and tolerability of REGN7257 in patients with immunosuppressive therapy (IST)-refractory or IST-relapsed severe aplastic anemia (SAA). An additional primary objective (for Part B only) is...

Microcephaly, Fanconi Anemia and Praxial Disorders
https://clinicaltrials.gov/ct2/show/NCT04656171

Feb 3rd, 2023 - Our hypothesis is that children with FA present a developmental dyspraxia. This condition is very penalizing for children especially regarding graphic tasks, handwriting, whether or not they have skeletal malformations of the upper limbs. Conseque...

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab
https://clinicaltrials.gov/ct2/show/NCT03472885

Feb 3rd, 2023 - The purpose of this study is to determine the effectiveness of danicopan in improving anemia, as measured by increased blood hemoglobin, when given with eculizumab (a drug commonly used for treatment of PNH) for 24 weeks in participants with PNH. ...

Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
https://clinicaltrials.gov/ct2/show/NCT05687149

Feb 3rd, 2023 - Study Description: This is a natural history study involving questionnaires, clinical and research evaluations, clinical and research laboratory tests, review of medical records, and cancer surveillance. A prospective cohort of individuals with Fa...

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias
https://clinicaltrials.gov/ct2/show/NCT05502783

Feb 3rd, 2023 - Study Description: This open label phase II trial is designed to evaluate the efficacy of fostamatinib in the treatment of post-transplant cytopenias as assessed by hematologic improvement in anemia and/or thrombocytopenia following a 12-week trea...

see more →

News  5,791 results

Novel 'Off the Shelf' CAR-T Product Shows Promise in Myeloma
https://www.medpagetoday.com/hematologyoncology/myeloma/102943

Feb 2nd, 2023 - Use of an allogeneic B-cell maturation antigen (BCMA)-targeting CAR T-cell therapy was feasible and safe and induced responses in patients with relapsed or refractory multiple myeloma, according to interim results from the phase I UNIVERSAL trial....

First Oral Treatment for CKD Anemia OK'd for Patients on Dialysis
https://www.medpagetoday.com/nephrology/anemia/102928

Feb 2nd, 2023 - The FDA approved the first oral agent for chronic kidney disease (CKD)-related anemia for adults on dialysis, the agency announced late on Wednesday. Daprodustat (Jesduvroq) is a once-daily tablet specifically indicated for patients who have been ...

Fungal Osler Nodes Indicate Candidal Infective Endocarditis
https://www.mdedge.com/dermatology/article/260955/infectious-diseases/fungal-osler-nodes-indicate-candidal-infective
Lauren E. Tisdale, MD, Cathy M. Massoud, MD et. al.

Jan 31st, 2023 - To the Editor: A 44-year-old woman presented with a low-grade fever (temperature, 38. 0 °C) and painful acral lesions of 1 week’s duration.

JAK Inhibitor Improves Symptoms, Anemia in Myelofibrosis
https://www.medpagetoday.com/hematologyoncology/othercancers/102883

Jan 30th, 2023 - Myelofibrosis treatment with the Janus kinase (JAK) inhibitor momelotinib resulted in clinically significant improvements in symptoms and spleen response compared with danazol for symptomatic, JAK inhibitor-exposed patients with anemia and interme...

Physician group issues 31 treatment recommendations for early-onset colorectal cancer
https://www.mdedge.com/internalmedicine/article/260906/oncology/physician-group-issues-31-treatment-recommendations-early

Jan 30th, 2023 - An international group of physicians has issued consensus recommendations for the diagnosis and management of patients with early-onset colorectal cancer (eoCRC). Led by Giulia Martina Cavestro, MD, PhD, a gastroenterologist with the University Vi.

see more →

Patient Education  292 results see all →